TAK
Takeda Pharmaceutical Company Limited
$16.48
Earnings Summary
Revenue | $811048Mn |
Net Profits | $53844Mn |
Net Profit Margins | 6.64% |
Highlights
Takeda Pharmaceutical Company Limited’s revenue jumped 88.28% since last year same period to $811048Mn in the Q3 2019. On a quarterly growth basis, Takeda Pharmaceutical Company Limited has generated -4.48% fall in its revenue since last 3-months.
Takeda Pharmaceutical Company Limited’s net profit jumped 11.19% since last year same period to $53844Mn in the Q3 2019. On a quarterly growth basis, Takeda Pharmaceutical Company Limited has generated 360.62% jump in its net profits since last 3-months.
Takeda Pharmaceutical Company Limited’s net profit margin fell -40.94% since last year same period to 6.64% in the Q3 2019. On a quarterly growth basis, Takeda Pharmaceutical Company Limited has generated 372.85% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the Takeda Pharmaceutical Company Limited post its latest quarter earnings
EPS Estimate Current Quarter | 0.15 |
EPS Estimate Current Year | 0.15 |
Highlights
Takeda Pharmaceutical Company Limited’s earning per share (EPS) estimates for the current quarter stand at 0.15 - a -54.49% fall from last quarter’s estimates.
Takeda Pharmaceutical Company Limited’s earning per share (EPS) estimates for the current year stand at 0.15.
Key Ratios
Key ratios of the Takeda Pharmaceutical Company Limited post its Q1 2023 earnings
Earning Per Share (EPS) | 0 |
Highlights
Takeda Pharmaceutical Company Limited’s earning per share (EPS) jumped 100% since last year same period to 0 in the Q1 2023. This indicates that the Takeda Pharmaceutical Company Limited has generated 100% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2019-07-31 | -0.19 | -0.06 | 67.68% |
2020-01-10 | 75 | 3 | -96% |
2019-10-31 | -0.21 | 0.16 | 176.19% |
2019-04-25 | -0.36 | -0.62 | -72.22% |
Company Information
The Takeda Pharmaceutical Company Limited is a Japanese multinational pharmaceutical company, with partial American and British roots. It is the largest pharmaceutical company in Asia and one of the top 20 largest pharmaceutical companies in the world by revenue.
Organisation | Takeda Pharmaceutical Company Limited |
Headquarters | 1-1, Nihonbashi-Honcho 2-chome, Tokyo, Japan, 103-8668 |
Employees | 47347 |
Industry | Health Technology |
CEO | Christophe Weber |
